- Home
- OMGA vs HKPD Comparison
OMGA vs HKPD Comparison
Compare OMGA & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMGA
- HKPD
- Stock Information
- Founded
- OMGA 2017
- HKPD 2016
- Country
- OMGA United States
- HKPD Hong Kong
- Employees
- OMGA N/A
- HKPD N/A
- Industry
- OMGA Biotechnology: Pharmaceutical Preparations
- HKPD Other Pharmaceuticals
- Sector
- OMGA Health Care
- HKPD Health Care
- Exchange
- OMGA Nasdaq
- HKPD Nasdaq
- Market Cap
- OMGA 27.1M
- HKPD 22.0M
- IPO Year
- OMGA 2021
- HKPD 2025
- Fundamental
- Price
- OMGA $0.16
- HKPD $1.77
- Analyst Decision
- OMGA Strong Buy
- HKPD
- Analyst Count
- OMGA 5
- HKPD 0
- Target Price
- OMGA $9.20
- HKPD N/A
- AVG Volume (30 Days)
- OMGA 26.1M
- HKPD 147.4K
- Earning Date
- OMGA 03-27-2025
- HKPD 01-01-0001
- Dividend Yield
- OMGA N/A
- HKPD N/A
- EPS Growth
- OMGA N/A
- HKPD N/A
- EPS
- OMGA N/A
- HKPD 0.18
- Revenue
- OMGA $8,095,000.00
- HKPD $16,688,364.00
- Revenue This Year
- OMGA $181.38
- HKPD N/A
- Revenue Next Year
- OMGA N/A
- HKPD N/A
- P/E Ratio
- OMGA N/A
- HKPD $9.84
- Revenue Growth
- OMGA 185.04
- HKPD 32.91
- 52 Week Low
- OMGA $0.10
- HKPD $1.66
- 52 Week High
- OMGA $4.46
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- OMGA 31.40
- HKPD N/A
- Support Level
- OMGA $0.15
- HKPD N/A
- Resistance Level
- OMGA $0.25
- HKPD N/A
- Average True Range (ATR)
- OMGA 0.08
- HKPD 0.00
- MACD
- OMGA 0.01
- HKPD 0.00
- Stochastic Oscillator
- OMGA 16.02
- HKPD 0.00
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.